1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with lenabasum in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
Aslan, S; Mitchell, VA; Safaei, R; Vaughan, CW | 1 |
Ahrens, J; Buchholz, V; de la Roche, J; Demir, R; Dengler, R; Foadi, N; Haeseler, G; Karst, M; Leuwer, M | 1 |
1 review(s) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and lenabasum
Article | Year |
---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and lenabasum
Article | Year |
---|---|
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dronabinol; Excitatory Amino Acid Antagonists; Inflammation; Ligation; Male; Motor Activity; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2005 |
Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.
Topics: Allosteric Regulation; Amino Acid Sequence; Cannabidiol; Cell Line; Dronabinol; Humans; Mutation; Patch-Clamp Techniques; Receptors, Glycine | 2010 |